🔴 Abivax is trading 4.05% down today as hotter-than-expected PPI pressured growth stocks

Abivax is trading at $114.62 (-4.05%) after hotter-than-expected producer inflation pressured equities and rate-sensitive growth stocks.

• The S&P 500, Nasdaq Composite and Dow Jones were each down more than 0.5%.
• No fresh company-specific negative catalyst was identified for September 10, 2026; investors are reassessing Federal Reserve rate-cut expectations after elevated PPI.
• Its next half-year results are scheduled for September 21, while Goldman Sachs recently initiated coverage with a Buy rating.